CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer. Researchers from Tel Aviv University (Israel), led by Razan Masarwy, have investigated utilizing CRISPR ...
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
Cap: Prof. Dan Peer (in blue) and his lab team at Tel Aviv University’s Laboratory of Precision Nanomedicine. Photo courtesy of Tel Aviv University March 23 By John Jeffay Researchers in Israel have ...
The research team: "Until now, CRISPR wasn't used for cancer because it was assumed that knocking out a single gene wouldn't topple the whole structure. We demonstrate that some genes are absolutely ...
Colorectal cancer (CRC) remains one of the most prevalent cancers worldwide and a leading cause of cancer mortality. Despite ...
New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with implications for a range of other cancers. Subscribe to our newsletter for ...
During Thanksgiving 2013, Emma Dimery, then 23, experienced intense stomach cramps. After a blood test during her annual physical uncovered low hemoglobin levels, she underwent numerous tests and ...
All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Learn more. At the ...
MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...
A promising new combination therapy is offering new hope for patients with hard-to-treat cancers. This is thanks to scientists at the Fralin Biomedical Research Institute in Virginia who have ...